Krystal Biotech, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Pittsburgh, PA
KRYS chart
What traders are saying about $KRYS
Latest postsKrystal Biotech, Inc. news
- Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth
Yahoo Finance ·
- Analysts Estimate Krystal Biotech, Inc. (KRYS) to Report a Decline in Earnings: What to Look Out for
Yahoo Finance ·
- Krystal Biotech (KRYS) Tests Its Multiproduct Story After Recent Pullback
Simply Wall Street ·
- Krystal Biotech Stock Price Forecast. Should You Buy KRYS?
StockInvest.us ·
- Krystal Biotech, Inc. Estimates – NASDAQ:KRYS
TradingView ·
- 3 US Biotech Stocks Investors Are Screening As China Capital Rules Tighten
Simply Wall Street ·
- Here's How Much $100 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today
Benzinga ·
- Krystal Biotech to Report Third Quarter 2026 Financial Results on November 2, 2026
Yahoo Finance ·
- Krystal Biotech to release Q3 2026 financial re...
Pluang ·
- Krystal Biotech, Inc. (KRYS) Stock Forecasts
Yahoo Finance ·
- Cystic Fibrosis Market Poised for Growth During the Forecast Period (2026-2036) as CFTR Modulators Transform Treatment Landscape | DelveInsight
Yahoo Finance ·
- Regeneron, Vidac Pharma, Krystal Biotech: New Active Ingredients, Enormous Stock Market Potential
Stockhouse ·
Krystal Biotech, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $389.1M | $290.5M | $50.7M | $0 |
| Net income | $204.8M | $89.2M | $10.9M | -$140.0M |
| Diluted EPS | $6.84 | $3.00 | $0.39 | $-5.49 |
| Total assets (year end) | $1.33B | $1.06B | $818.4M | $558.5M |
| Cash and equivalents (year end) | $496.3M | $344.9M | $358.3M | $161.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Krystal Biotech, Inc.
- Ticker
- KRYS (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Pittsburgh, PA
- Fiscal year end
- December 31
- SEC CIK
- 1711279
Frequently asked questions
What exchange is Krystal Biotech, Inc. listed on?
Krystal Biotech, Inc. trades on the Nasdaq under the ticker symbol KRYS.
What industry is Krystal Biotech, Inc. in?
Krystal Biotech, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Krystal Biotech, Inc. headquartered?
Krystal Biotech, Inc.'s business address on file with the SEC is in Pittsburgh, PA.
When does Krystal Biotech, Inc.'s fiscal year end?
Krystal Biotech, Inc.'s fiscal year ends on December 31.
How much revenue did Krystal Biotech, Inc. report?
Krystal Biotech, Inc. reported $389.1M in revenue for calendar year 2025, according to its SEC filings.